Takeda buys up biotech Millennium
April 14, 2008Sales and Marketing
Takeda has acquired US biotech company Millennium in an effort to boost its global presence in oncology. The Japanese firm …
Merck obesity drug to continue at low dose
April 11, 2008Research and Development, Sales and Marketing
New data suggests Merck's taranabant drug can help obese patients lose weight, but safety concerns look to be behind higher …
Study confers protective benefits on Micardis
April 4, 2008Sales and Marketing cv
Boehringer Ingelheim's hypertension treatment Micardis has come out on top of Aventis's gold standard ACE inhibitor Tritace in a new …
UK clinical research is being transformed
April 4, 2008Research and Development UK, clinical trials
Politicians have been talking, reports have been published, a series of initiatives have been launched and a fist full of …
Trial fails to enhance Inegy’s prospects
April 4, 2008Sales and Marketing cv
Schering-Plough and Merck's much-touted anti-cholesterol combination Inegy has suffered a setback following a poor showing in the ENHANCE trial. Inegy …
Role of pharmacists to be extended
April 4, 2008Pharmacists are to be given a greater role in patient treatment and promoting good health under new government plans. The …
Make Alzheimer’s a top research priority, says public
April 1, 2008The British public wants a greater focus on research into Alzheimer's disease, according to an opinion poll conducted by the …
UCB’s Cimzia fails to appeal to European regulators
April 1, 2008Sales and Marketing EU
UCB's Crohn's disease drug Cimzia has been denied European approval for a second time after regulators said lacked sufficient evidence …
Latest news from Datamonitor
March 31, 2008Sales and Marketing
The impact of the US presidential race on healthcare IT The three leaders in the race for the US presidency; …
The role of audit in marketing excellence
March 28, 2008Sales and Marketing audit, excellence, marketing
The goal for any business leader, whether they run a company, business unit or brand, should always be 100% alignment …
Gardasil licence extension gets priority FDA review
March 28, 2008Sales and Marketing
Merck has received priority review status from the FDA for its application to extend the licence of its cervical cancer …
Accomplia gains limited NICE approval
March 28, 2008Sales and Marketing
Sanofi-Aventis' weight-loss pill Acomplia has been approved for prescription on the NHS, but only for patients who fail to respond …
Merck’s hepatitis B vaccine trial on hold
March 28, 2008Sales and Marketing
US regulators have placed a 'clinical hold' on one of the trials for Merck's hepatitis B vaccine Heplisav, raising questions …
Boehringer Ingelheim’s Pradaxa approved in Europe
March 28, 2008Sales and Marketing
European regulators have approved Boehringer Ingelheim's novel anti-clotting pill Pradaxa, paving the way it to be launched in the coming …
Pharming’s orphan drug receives second setback in Europe
March 26, 2008Sales and Marketing HAE, Pharming
Dutch biotech company Pharming has suffered a blow, after its lead product Rhucin was rejected by European regulators for a …
NHS Trusts to promote their services to the public
March 25, 2008Medical Communications
All patients needing routine hospital care will soon be able to choose from any approved NHS trust in the country. …
Latest news from Datamonitor
March 25, 2008Sales and Marketing em
Faced with dwindling growth rates in the US and Europe, drug companies are turning their attention towards emerging pharmaceutical markets …
Early access to experimental drugs for terminally ill
March 25, 2008Sales and Marketing
Terminally ill cancer patients are to get early access to developmental drugs in a bid to halve the time it …
GSK consolidates Cervarix PR ahead of crucial vaccine decision
March 25, 2008Medical Communications
GlaxoSmithKline has reorganised the PR support for its cervical cancer vaccine Cervarix, choosing just one agency to handle the UK …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
